The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Biomira Inc.

Biomira Inc.
Nasdaq: BIOM
Change
symbol:
     
 PROFILE
"Live long and prosper" -- with cancer? Biomira thinks it's possible. The firm focuses on developing synthetic vaccines that trigger a patient's immune system to identify and fight cancer cells without the damaging effects of radiation or chemotherapy. Its lead drug candidate is THERATOPE, a possible vaccine for breast cancer; the drug has received fast-track designation from the FDA. The firm has a worldwide marketing agreement with Merck KGaA for THERATOPE and BLP-25, a lung cancer vaccine candidate. With Biovector Therapeutics, the company is developing a lymphoma vaccine. It is also looking at applying its technologies to other cancers.

 COMPETITION
Corixa Corporation (CRXA)
Progenics Pharmaceuticals, Inc. (PGNX)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 3.10
1-Yr. Sales Growth: 47.6%
Employees: 180
Revenue per employee: $17,222.22

 KEY PEOPLE
• T. Alexander McPherson
    CEO
• Edward A. Taylor
    CFO

 CONTACT INFO
2011 94th St.
Edmonton Alberta T6N 1H1, Canada
Phone: 1-780-450-3761
Fax: 1-780-463-0871
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001